Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cervus and cucumis polypeptide injection for fracture healing
ChiCTR1900021906Phase 4Recruiting
- Sponsor
- 中国中医科学院望京医院
- Start
- Dec 2018
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of cervus and cucumis polypeptide in bone fracture (Fx) and tibia fracture (2 arms), sponsored by 中国中医科学院望京医院. Primary endpoint: Radiological evaluation. Started Dec 2018; status: recruiting.
02
Drugs
cervus and cucumis polypeptide
03
Conditions
bone fracture (Fx)tibia fracture
Beyond the preview
Go deeper on ChiCTR1900021906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021906.